je.st
news
Tag: new
Pfizer says it could be leader in cancer with many new drugs
2015-09-22 20:12:21| Biotech - Topix.net
Drug giant Pfizer is starting 20 clinical trials this year and more soon after on treatments to conquer cancer as it also seeks to gain leadership in one of the hottest, and most lucrative, areas of medicine. A decade ago, the world's second-biggest drugmaker by revenue wasn't even a player in cancer medicine.
From spies to smartphones: Britain's Aga set for another new chapter
2015-09-22 13:51:06| Industrial Machines - Topix.net
LONDON: The sale of oven maker Aga Rangemaster to a U.S. owner with global ambitions caps the transformation of a quintessential English country brand created by some of the biggest names in global design, advertising: and espionage. The acquisition of Aga for US$202 million by Middleby Corporation follows a brief bidding war with U.S. rival Whirlpool for the maker of the colourful cast-iron stoves that can weigh as much as a male polar bear, cost US$18,000 and, in older versions, take two days to heat.
Tags: new
set
chapter
smartphones
PNM Resources, Inc. (PNM) - Alternative Energy - Deals and Alliances Profile - New Report Available
2015-09-21 20:15:38| Energy - Topix.net
Alternative Energy - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions , partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period.
Tags: new
available
report
profile
Coal Ash Flowing Into Groundwater, Milliken Creek in New York
2015-09-21 15:29:00| Waste Age
Ithaca Journal Coal ash sitting dormant in an unlined portion of the landfill near the Cayuga Power Plant has been seeping into groundwater for nearly 30 years. read more
Data in Nine Difficult-to-Treat Cancers from Mercks KEYTRUDA (pembrolizumab) Development Program to be Presented at European Cancer Congress 2015, Including Data in Four New Cancer Types: ...
2015-09-21 14:00:00| Merck.com - Product News
Dateline City: KENILWORTH, N.J. ...Nasopharyngeal Carcinoma, Anal Cancer, Merkel Cell Carcinoma and Biliary Tract Cancer Data to Include First-Time Findings on the Potential Importance of PD-L2 Expression in Predicting Patient Responsiveness to Anti-PD-1 Therapy KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that new data investigating the anti-tumor activity of KEYTRUDA (pembrolizumab) across a broad range of advanced cancers will be presented at this years European Cancer Congress (ECC) in Vienna, Austria, Sept. 25-29. In total, 15 KEYTRUDA-related abstracts across nine difficult-to-treat cancers will be presented at this years ECC including four late-breaking oral presentations. Language: English Contact: MerckMedia:Pamela Eisele, 267-305-3558orAn Phan, 908-255-6325orInvestors:Teri Loxam, 908-740-1986orJustin Holko, 908-740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Sites : [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] next »